Metaxalone

美他沙酮

Report date: 2025/08/19 13:50:28
NME

Base Information

Drug NameMetaxalone
Drug Alias Name美化沙酮SkelaxinSkelaxin HBAHR-438
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase A inhibitorsMuscle relaxation agentsCentral nervous system modulators +[5] 
TargetsMonoamine oxidase AInterleukin-1 betaNuclear factor NF-kappa-B complex
Therapy Area/IndicationsMuscle Spasticity
Global Approved IndicationsMuscle Spasticity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1962/08/13
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaDiscontinued
Originator CompaniesKing Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing Pharmaceuticals IncStaidson(Beijing) Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsMuscle Spasticity

Other Information

ATC CodeM03
Related LinksWikipediaDrugBankKEGG